The short answer: Rule 701 is the SEC exemption that lets a private company grant stock options, RSUs and shares to its employees, directors and qualifying consultants without registering those securities. In any consecutive 12-month period, Rule 701 sales cannot exceed the greatest of $1 million, 15% of total assets, or 15% of the outstanding securities of the class. Once sales in a 12-month period pass $10 million, the company must also give every participant a plan summary, risk factors and financial statements no more than 180 days old. Grants must sit under a written compensatory plan, and the exemption can never be used to raise capital.
Equity is how a young company competes for people it cannot yet afford in cash. The catch is that every stock option is a security, and US law says securities must be registered with the SEC unless an exemption applies. For almost every private company, that exemption is Rule 701.
The rule is simple to describe and easy to get wrong. Founders mix up the 12-month ceiling with the $10 million disclosure trigger, count options at the wrong value, or assume one year’s grants cannot affect the next. In our valuation work with US startups and the CPA firms that advise them, the Rule 701 math and the 409A math tend to break together, because both depend on what an award is worth on the day it is granted.
This guide covers who can use Rule 701, how the limits work, what the SEC staff clarified in its March 6, 2026 guidance, and where a defensible valuation fits in.
Key Takeaways
- Rule 701 exempts compensatory equity grants by private, non-reporting companies from SEC registration when they are made under a written plan or contract.
- The 12-month ceiling is the greatest of $1 million, 15% of total assets, or 15% of the outstanding class, and passing any one test is enough.
- The $10 million threshold is a separate disclosure trigger, not a cap, and it requires a plan summary, risk factors and financial statements no older than 180 days.
- Stock options count at their exercise price on the grant date, and RSUs are treated as sold on the grant date, not at vesting or settlement.
- Both limits apply to any consecutive 12-month period, so a company cannot escape them by choosing a fiscal-year window.
- SEC staff guidance issued on March 6, 2026 says a missed disclosure can cost the exemption for the entire offering in that 12-month period.
- Rule 701 is federal only, so each state where recipients live needs its own exemption.
What Is Rule 701 and Who Can Use It?
Rule 701 is an exemption under the Securities Act of 1933 that the SEC adopted in 1988. It allows a company that is not an SEC reporting company to issue securities as compensation without filing a registration statement. A registration statement is the full disclosure filing a public offering requires, and it is far too costly for routine option grants.
Three conditions sit at the heart of the rule. The issuer must be eligible, the recipients must be eligible, and the grant must be made under a written compensatory arrangement.
Which companies qualify?
The company must not be subject to Exchange Act reporting under Section 13 or 15(d), and it cannot be a registered investment company. In practice, this covers most venture-backed startups and privately held operating businesses. Public companies register their equity plans on Form S-8 instead.
Who can receive equity under Rule 701?
Eligible recipients include employees, directors, officers, general partners and trustees of the company, its parent, or its majority-owned subsidiaries. Consultants and advisors also qualify, but only if they are natural persons providing bona fide services. Their work cannot relate to raising capital or to promoting a market for the company’s stock.
Former employees are covered only for grants offered while they were still providing services. That point matters when a company tries to reward someone after they leave.
Why the written plan matters
Rule 701 only exempts grants made under a written compensatory benefit plan or a written compensation contract. A board resolution approving an equity incentive plan, plus individual award agreements, normally satisfies this. A handshake promise of “some equity” does not, and every recipient must receive a copy of the plan.
Not sure whether your option grants, advisor awards or former-employee grants actually fit inside Rule 701?
Countsure reviews your equity plan, grant history and cap table against the Rule 701 conditions and flags any award that falls outside the exemption. You get a written summary of what fits, what does not, and what to fix before your next grant.
What Are the Rule 701 Limits?
Rule 701 caps how much a company can sell under the exemption in any consecutive 12-month period. The ceiling is the greatest of three tests, so the company gets whichever figure is most generous. This ceiling is a hard limit on the exemption itself, not a disclosure trigger.
Test |
Measure |
Who it usually helps |
|---|---|---|
Flat dollar test
|
$1 million aggregate sales price
|
Very early companies with small balance sheets
|
Asset test
|
15% of total assets at the most recent balance sheet date
|
Companies that have raised significant capital
|
Share test
|
15% of the outstanding securities of the class being offered
|
Companies with a large base of common shares
|
How is an equity award counted toward the limit?
For stock options, the aggregate sales price is the exercise price, and the option is counted when it is granted. Vesting and exercise do not create a new count. If the company reprices options downward, the SEC staff treats the repricing as a new sale in the 12-month period that includes the repricing date.
For RSUs, the sale date is the grant date, not the later settlement date. Shares issued for services must be given a real value rather than treated as free, because the SEC does not let companies value compensatory stock at zero. This is where the fair market value of the common stock starts to matter.
What Happens When Rule 701 Grants Exceed $10 Million?
When the aggregate sales price or amount of securities sold under Rule 701 exceeds $10 million in a consecutive 12-month period, the company must deliver extra disclosure to every participant. The threshold was raised from $5 million to $10 million in 2018 following the Economic Growth, Regulatory Relief, and Consumer Protection Act. The required package has three parts:
- A summary of the plan. A plain description of the material terms of the compensatory plan or contract.
- Risk factors. The material risks of holding the company’s securities.
- Financial statements. Statements that meet the Regulation A standards and are as of a date no more than 180 days before the sale.
The disclosure must arrive a reasonable period before the sale. For options, that means a reasonable period before the option is exercised. The 180-day rule is demanding for private companies, because it effectively requires fresh financial statements at least twice a year while the threshold is exceeded, and quarterly in many cases.
What did the SEC staff clarify on March 6, 2026?
On March 6, 2026, the SEC’s Division of Corporation Finance issued new and revised Compliance and Disclosure Interpretations on Rule 701. Compliance and Disclosure Interpretations are the staff’s published answers to recurring questions. Four points matter most for private companies:
- The disclosure should go to all participants in any 12-month period in which the company expects to cross $10 million, not only those who receive grants after crossing it.
- Failing to deliver the disclosure can cost the company the exemption for the entire offering in that period.
- The trigger turns on the value of options granted, measured by exercise price, not on vesting or exercise amounts.
- If only one 12-month period exceeds the threshold, the disclosure duty and any loss of the exemption are confined to that period’s offering.
The practical message is to forecast, not just look back. A company planning a large refresh grant after a funding round should decide in advance whether the next 12 months will cross $10 million.
How Is the 12-Month Period Measured?
Both the ceiling and the $10 million trigger apply to any consecutive 12-month period. That means the test effectively rolls: every new grant must be checked against the 12 months ending on its grant date. A company cannot pick its fiscal year as the only window and ignore grants that straddle two fiscal years.
This is a common misreading. Some guides describe a choice between a fixed calendar window and a rolling window, and suggest that clustering grants across two fiscal years can keep a company below the trigger. It cannot, because any 12-month stretch that captures those grants still counts.
The practical fix is a simple grant log. Record each award’s grant date, share count and exercise price or value, then total the trailing 12 months before every board approval.
A Worked Example: Two Companies, Two Different Limits
Consider two hypothetical private companies granting options in the same 12-month period. The numbers are illustrative, but the arithmetic follows the rule.
Harborline Robotics, seed stage
- Total assets at the most recent balance sheet date: $4,000,000
- Outstanding common shares: 10,000,000
- Options granted in the trailing 12 months: 1,200,000 shares at a $0.90 exercise price
The aggregate sales price is 1,200,000 × $0.90 = $1,080,000. That exceeds the $1,000,000 dollar test and the asset test of 15% × $4,000,000 = $600,000. However, the share test allows 15% × 10,000,000 = 1,500,000 shares, and 1,200,000 shares is below that. Harborline stays within the ceiling. At $1,080,000, it is also far below the $10 million disclosure trigger.
Crestview Analytics, after its Series B
- Total assets at the most recent balance sheet date: $60,000,000
- Outstanding common shares: 100,000,000
- Options granted in the trailing 12 months: 8,000,000 shares at a $1.40 exercise price
The aggregate sales price is 8,000,000 × $1.40 = $11,200,000. The ceiling is not a problem, because the asset test allows $9,000,000 and the share test allows 15,000,000 shares, and 8,000,000 shares fits inside the larger share test. But $11,200,000 crosses the $10 million trigger. Crestview must give every participant in that 12-month period the plan summary, risk factors and financial statements no older than 180 days.
The lesson is that the two limits answer different questions. The ceiling asks whether the exemption is available at all. The trigger asks what the company must hand to recipients.
What Are the Most Common Rule 701 Mistakes?
Most Rule 701 problems are not exotic. They come from a handful of recurring errors that surface during a financing, an acquisition or IPO diligence.
- Treating the ceiling and the trigger as one number. The greatest-of-three test limits the exemption, and $10 million triggers disclosure. They are separate checks.
- Counting only the fiscal year. Any consecutive 12 months counts, so grants that straddle year end must be totalled together.
- Starting disclosure too late. The March 2026 staff guidance expects disclosure to every participant once the company expects to cross $10 million.
- Letting financial statements go stale. Statements older than 180 days at the time of sale do not satisfy the rule.
- Granting to ineligible recipients. Entity consultants, fundraising advisors and promoters fall outside the exemption.
- Ignoring state law. A clean federal position still needs a state exemption where recipients live.
- Pricing options without a current valuation. A weak strike price creates tax exposure and undermines the numbers used in the Rule 701 count.
Worried that your trailing 12 months of grants are closer to the $10 million trigger than you thought?
Book a call with Countsure and we will total your trailing grants against all three Rule 701 tests and the disclosure trigger. We will also tell you whether your current 409A supports the strike prices you have already issued.
How Does Rule 701 Compare With Other SEC Exemptions?
Rule 701 is often confused with the other routes companies use to issue securities. Each one solves a different problem, and using the wrong one is where compliance breaks.
Mechanism |
Used by |
What it is for |
|---|---|---|
Rule 701
|
Private companies
|
Compensatory grants to employees, directors and qualifying consultants. Never for raising capital.
|
Regulation D
|
Private companies
|
Raising capital, mainly from accredited investors, without full registration.
|
Form S-8
|
Public companies
|
Registering securities issued under employee benefit plans.
|
Regulation CF
|
Early-stage companies
|
Raising money from the public through registered crowdfunding portals, within annual limits.
|
The easy way to keep them straight: Rule 701 and Form S-8 are about paying your team, private versus public. Regulation D and Regulation CF are about raising money.
Where Does a 409A Valuation Fit Into Rule 701 Compliance?
What Happened to the Proposed 2020 Rule 701 Amendments?
On November 24, 2020, the SEC proposed changes that would have raised the dollar test from $1 million to $2 million and the asset test from 15% to 25%. The proposal would also have applied the $10 million disclosure only to sales above the threshold and, in a companion release, allowed grants to certain gig-economy platform workers on a temporary basis.
Those amendments were proposed, not adopted. The March 2026 staff guidance applies the existing rule, including the $10 million trigger, so companies should plan around the current limits. Confirm the status with securities counsel before relying on any change.
Frequently Asked Questions
1. What is Rule 701 in simple terms?
Rule 701 is an SEC exemption that lets private, non-reporting companies grant stock options, RSUs and shares to employees, directors, officers, consultants and advisors without registering those securities. The grants must be made under a written compensatory plan or contract and stay within the rule’s 12-month limits.
2. What is the Rule 701 limit?
In any consecutive 12-month period, a company can sell no more under Rule 701 than the greatest of $1 million, 15% of its total assets, or 15% of the outstanding securities of the class being offered Meeting any one of the three tests is enough
3. When does the Rule 701 $10 million disclosure rule apply?
It applies when the aggregate sales price or amount of securities sold under Rule 701 exceeds $10 million in any consecutive 12-month period The company must then give every participant in that period a plan summary, risk factors and financial statements no older than 180 days
4. How are stock options counted toward the Rule 701 limits?
Options are counted when they are granted, not when they vest or are exercised, and they are valued at their exercise price SEC staff guidance issued on March 6, 2026 confirms this and adds that a downward repricing counts as a new sale
5. Can a company use Rule 701 to raise money from investors?
No Rule 701 covers compensatory grants only Selling shares to investors for capital needs a different route, most often Regulation D for accredited investors or Regulation CF for crowdfunding
6. Can consultants and advisors receive equity under Rule 701?
Yes, if they are natural persons providing bona fide services to the company Their services cannot be connected to raising capital or to promoting or maintaining a market for the company’s securities
7. Does Rule 701 exempt a company from state securities laws?
No Rule 701 is a federal exemption and does not preempt state blue sky laws Companies also need a state exemption where recipients live, and California, for example, has its own compensatory plan exemption with a notice filing
8. Do I need a 409A valuation to grant options under Rule 701?
Rule 701 does not require one, but tax law effectively does Options priced below fair market value on the grant date can fall under Section 409A penalties, so an independent 409A valuation is the standard way to set a defensible strike price
Conclusion: Getting Rule 701 Right for Your Equity Plan
Rule 701 lets private companies grant equity without registration, as long as grants follow a written plan, go to eligible recipients and stay within the greatest of $1 million, 15% of assets or 15% of the class Once any 12-month period passes $10 million, full disclosure to every participant becomes mandatory The March 2026 staff guidance makes the stakes clear, because a missed disclosure can cost the exemption for the whole offering The companies that stay safe treat Rule 701 as a running calculation, not a one-time check, and they anchor every grant to a current valuation
- Keep a grant log with grant date, share count and exercise price, and total the trailing 12 months before every board approval
- Check the ceiling and the trigger separately, because they answer different questions
- Start disclosure early in any 12-month period you expect to exceed $10 million, and keep financial statements within 180 days
- Confirm recipient eligibility, especially for consultants, advisors and former employees
- Refresh your 409A before large grants or after a financing, so strike prices and Rule 701 counts rest on the same defensible number
Get these five habits in place now, and your next financing or acquisition diligence will be far easier
Granting equity under Rule 701 and need a strike price you can defend?
Countsure prepares independent, audit-ready 409A valuations under Licensed US CPA supervision, with a draft report typically delivered in 9 to 12 working days Each report is built to support your option pricing, your Rule 701 counts and any disclosure package
Related Countsure Blogs
- 409A Valuation vs. Fair Market Value: Key Differences: why a general FMV figure carries no IRS presumption and a 409A appraisal does.
- What Is a 409A Valuation? The Essential Guide to Avoiding Costly IRS Penalties in 2026: the penalties that follow mispriced options and how to avoid them.
- 409A Valuation Methods: A Founder’s Guide to Pre-OPM Value: how the market, income and asset approaches set enterprise value before the option pricing model.
Parth Shah, Managing Director
(CPA-US, FCA, RV-S&FA, DISA)
Parth Shah who is head of Accounts and Book keeping has experience of more than 10 years. A Certified Public Accountant – US, fellow Chartered Accountant, Registered Valuer and Diploma in Information System Audit.
